These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 5155338)

  • 1. [The importance of indices of non-specific immunity in gynecologic patients].
    Malkov IaIu
    Akush Ginekol (Mosk); 1971 Jul; 47(7):60-2. PubMed ID: 5155338
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoglobulin level in malignant gynecologic diseases and tumor patients].
    Pulay T; Keller G; Krommer K; Kovács C
    Orv Hetil; 1973 Dec; 114(52):3146-8. PubMed ID: 4766323
    [No Abstract]   [Full Text] [Related]  

  • 3. [The properdin content of the blood serum of patients with tuberculosis].
    Tatarinova NV
    Probl Tuberk; 1968; 46(4):48-53. PubMed ID: 5670972
    [No Abstract]   [Full Text] [Related]  

  • 4. [Phagocytic reaction indices in malignant neoplasms and other diseases of the gynecologic organs].
    Kovbasiuk RF; Vovchuk VA
    Akush Ginekol (Mosk); 1969 Mar; 45(3):16-8. PubMed ID: 5406950
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of T-lymphocytes in patients with a gynecologic malignancy].
    Ressel M; Köhler G
    Zentralbl Gynakol; 1984; 106(17):1192-7. PubMed ID: 6333766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on cell-mediated immune functions of patients with gynecologic tumors. Cytotoxic activity to human ovarian cancer cell lines and reactivity to phytohemagglutinin shown by lymphocytes.
    Fukuda Y
    Keio J Med; 1983 Dec; 32(3-4):81-98. PubMed ID: 6679586
    [No Abstract]   [Full Text] [Related]  

  • 7. [Importance of CA-50 detection in malignant gynecologic tumors].
    Indraccolo SR; Greco A; Cartechini MG; Compagnucci P
    Minerva Ginecol; 1990 Dec; 42(12):507-9. PubMed ID: 2089292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Some immunological reactivity indices in ovarian and uterine neoplasms].
    Gorodilov VV; Kochetkova VA; Sokolova II; Lastochkina VI
    Vopr Onkol; 1974; 20(1):50-6. PubMed ID: 4612971
    [No Abstract]   [Full Text] [Related]  

  • 9. [T and B lymphocytes, IgG, IgA and IgM in women with genital neoplasms].
    Paruch J; Lisiewicz J; Liber Z
    Wiad Lek; 1982 Oct; 35(18):1143-8. PubMed ID: 7179988
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers.
    Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
    Am J Obstet Gynecol; 2000 Jul; 183(1):18-21. PubMed ID: 10920302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca-125 levels in the conditioned media of the gynecological tumor cell lines.
    Ishiwata I; Ishiwata C
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jan; 37(1):147-8. PubMed ID: 3855943
    [No Abstract]   [Full Text] [Related]  

  • 12. [Carcinoembryonic antigen in gynecological oncology].
    Stiglmayer R
    Fortschr Med; 1978 Oct; 96(37):1843-5. PubMed ID: 700565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Characteristics of the immunological status of endometriosis patients].
    Suprun LIa
    Akush Ginekol (Mosk); 1983 Feb; (2):41-4. PubMed ID: 6601920
    [No Abstract]   [Full Text] [Related]  

  • 14. [Delayed hypersensitivity reaction of the skin in women with malignant genital neoplasms].
    Markowska J
    Ginekol Pol; 1981 Jan; 52(1):63-8. PubMed ID: 7286730
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte cytotoxicity against allogeneic cultured cells in gynecologic malignancy.
    Arata T; Momozaki F; Kazuta M; Yamamoto H; Sekiba K
    Acta Med Okayama; 1979 Jun; 33(3):197-204. PubMed ID: 158947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of CA 19-9 as a tumor marker for gynecologic malignancies].
    Inoue M; Saitoh J; Abe Y; Inoue Y; Ueda G; Tanizawa O; Gamoh Y; Dan A; Satoh T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2411-4. PubMed ID: 3865972
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biochemical indicators of neoplasms of the female genital organs].
    Kamiński K
    Ginekol Pol; 1988 Jun; 59(6):376-80. PubMed ID: 3069618
    [No Abstract]   [Full Text] [Related]  

  • 18. [Fundamental and clinical study on source of CA 125 antigen in cul-de-sac fluid and translation into systemic circulation].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Apr; 41(4):390-6. PubMed ID: 2746065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on the plasma plasminogen activators in patients with malignant gynecologic tumors].
    Shimada H; Ikeuchi M; Suwa M; Michimoto T; Ono Y; Tanada S; Himeno K; Hoshino T; Takashima E
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1353-9. PubMed ID: 2511260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor antigens CA 125 and CA l9-9 in the serum of patients with gynecologic trophoblastic tumors and colorectal carcinoma].
    Göcze P; Szabó D; Than G; Csaba I; Krommer K
    Orv Hetil; 1986 Aug; 127(35):2123-6. PubMed ID: 3024089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.